The efficacy, tolerability, and safety of other forms of anti-seizure treatment, such as the mammalian target of rapamycin (mTOR) inhibitors, like rapamycin (Sirolimus), have been researched in other pediatric seizure disorders, as well as in SWS [5]. Here, MTOR is linked to epilepsy.